Back to Results
First PageMeta Content
Cell biology / Developmental biology / Emerging technologies / Cell therapy / Dendreon / Cytori Therapeutics / Cancer vaccine / Immunotherapy / Regenerative medicine / Biology / Biotechnology / Stem cells


Document Date: 2013-12-22 03:31:08


Open Document

File Size: 58,44 KB

Share Result on Facebook

City

Osaka / /

Company

Biotherapeutics Inc. / NeoStem Inc. / Susquehanna International Group / ImmunoCellular Therapeutics Ltd. / Inovio Pharmaceuticals Inc. / OncoSec Medical Inc. / Baxter International Inc. / Cytori Therapeutics Inc. / Pfizer Inc. / StemCells Inc. / Roche Holding AG / Advanced Cell Technology Inc. / Maxim Group / ImmunoCellular Therapeutics Inc. / Mesoblast Ltd. / Athersys Inc. / Agenus Inc. / Northwest Biotherapeutics Inc. / Pluristem Therapeutics Inc. / Dendreon Corp. / United Therapeutics Corp. / Roche Pharmaceuticals / Therapeutics Ltd. / Salomon Smith Barney / Osiris Therapeutics Inc. / Regeneron Pharmaceuticals Inc. / Teva Pharmaceutical Industries Ltd. / Schering-Plough / Prochymal / /

Country

Japan / Australia / United States / /

Currency

USD / /

Event

Business Partnership / FDA Phase / M&A / /

Facility

University of New Haven / State University of New York / /

IndustryTerm

allogeneic product / therapy for heart failure / machinery / healthcare fund / manufacturing process / biotechnology research / e-newsletter / autologous products / approvable product / tha healthcare system / electroporation technology / healthcare / pharmaceutical / autologous cell therapy product / autologous product / healthcare sector / healthcare system / biotechnology field / biotechnology team / therapies for stroke / therapy for stroke / /

MedicalCondition

full-blown cervical cancer / ischemic stroke / macular degeneration / Crohn's / melanoma / chronic myocardial ischemia phase / prostate cancer / massive heart attack / glioblastoma / cervical intraepithelial neoplasia grade II / tumor / cancer / HPV / cervical cancer / stroke / diabetes / cervical intraepithelial neoplasia / ulcerative colitis / chronic disease / hepatitis B. This / dry macular degeneration / degenerative disk disease / degenerative disc disease / ST-elevated myocardial infarction / graft-versus-host disease / CIN / chronic congestive heart failure / respective glioblastoma trials / hypertension / patient's own tumor / disease / cardiovascular disease / heart failure / heart attack / glioblastoma trial / /

MedicalTreatment

immunotherapy / cell therapy / vaccine therapies / catheter / apheresis / /

Organization

University of New Haven / Japanese government / Ministry of Health / State University of New York / U.S. Food and Drug Administration / /

Person

George S. Mack / Michael Hay / Joseph Kim / Jason Kolbert / Craig C. Mello / Jocelyn August / /

Position

healthcare strategist / product manager / cofounder and CEO / engineer / managing director / interventional cardiologist / fund manager / independent contractor / analyst / that pivotal studies / equity analyst / analyst / manager for a leading pharmaceutical company / managing director for biotechnology research / /

Product

STEMI / ICT-107 / AMR-001 / Japan / Prochymal / MultiStem / /

Region

Northwest / /

Technology

cell therapy / stem cells / electroporation technology / genotype / biotechnology / electroporation / drug development / regenerative medicine / /

URL

http /

SocialTag